Clinical Research Medical

Arun Chakrabarty, M.D.

Curriculum Vitae March *020

Contact Address

**** **** ******* ***., #***

Hemet, CA 92543

Cell: 530-***-****

Email: *********@*****.***

Education

Undergraduate University of California, San Diego, La Jolla

9/90-8/94

BA Major- Economics

Minor-Biochemistry

Graduate Loma Linda University School of Medicine

Loma Linda, California

MD, 1/98-6/01

Transferred from St. George’s Univ SOM (‘98)

St. George’s Univ SOM ‘95-‘97

Grenada, West Indies (no degree conferred)

07/01/11-06/30/2014 Internal Medicine Residency

ST. MARY MEDICAL CENTER Long Beach/UCLA HARBOR

TORRANCE

Board Certified- Internal Medicine (ABIM): Oct 2014 (FIRST PASS)

Medical School Honors/Awards

Timely Completion Dictations (Resident Record at Internal Medicine

Residency at St. Mary’s Medical Center Long Beach, CA)

Honors in Trauma Surgery, senior year, one month elective

Top 10% of class of Basic Science, sophomore year

High Marks in Physiology, Pharmacology, Microbiology

(see last page of Dean’s letter): USMLE equivalent 235-240

o

Other Awards/Accomplishments

Winter Quarter 1992, University California San Diego

Provost's academic award

Fall Quarter 1993, University California San Diego

Provost's academic award

Spring Quarter 1994, University California San Diego

Provost's academic award

Examinations:

10/14 American Board of Internal Medicine (ABIM) – certified

04/08 OKAP (Ophthalmology Knowledge Self-Assessment

Program) PGY-2 level 66 percentile (highest among first

year ophthalmology Univ. of Kansas residents in program

for 2008)

12/01 USMLE Step 3, Passed

12/00 USMLE Step 2, Score 220

06/99 USMLE Step 1 Equivalent 235-240 (last page Dean’s

letter)

06/97 USMLE Step 1, Score 217

State Licenses

Fully Active California Medical License

Languages (other than English)

Bengali, Hindi, and high-school level Spanish

WORK PLACES:

07/01/2019-03/15/2020 HAZELDEN BETTY FORD ADDICTION MEDICINE

ADDICTION PRACTICE PATHWAY

10/2018-CURRENT MERCY MEDICAL CENTER

REDDING, CA

10/2018-CURRENT ST. ELIZABETH COMMUNITY HOSPITAL

RED BLUFF, CA

08/2018-08/2019 OAK VALLEY HOSPITAL

Oak Valley, CA

05/2017-05/2018 Petaluma Valley Hospital

Petaluma, CA

05/2017-01/24/2020 QUEEN OF THE VALLEY

NAPA, CA

12/2014-CURRENT DESERT REGIONAL MEDICAL CENTER

Cambridge Hospitalist(FULL TIME from 12/14-04/16)

PALM SPRINGS, CA

Full Privileges

2016- August 2017 Part-time Faculty to UCR Family Practice Residency at

Desert Regional Medical Center (Many

Residents from Loma Linda, UCLA, UC Davis)

Nov 2016-Sept 2017 SAN GORGONIO MEMORIAL HOSPITAL

BANNING, CA

Full Privileges expired/not renewed

May 2016-Nov 2016 ANTELOPE VALLEY HOSPITAL

LANCASTER, CA

Second Busiest Emergency Room in southern California

after USC Keck County Hospital in downtown LA

Prior Full Privileges: no longer as not renewed

Postgraduate: Residency/ Research Fellowships

07/01/11-06/30/2014 Internal Medicine Residency

ST. MARY MEDICAL CENTER Long Beach/UCLA HARBOR

TORRANCE

Board Certified- Internal Medicine (ABIM): Oct 2014 (FIRST PASS)

3/11-7/2011 Part-time volunteer ER at Hemet Valley

10/09-04/11 Part-time Research w/ Dr. Sinha

University of Southern California (USC)

Head and Neck Surgery

Los Angeles, CA

8/08-8/09 PGY-3 Ophthalmology resident

Virginia Commonwealth Univ. (VCU) Dept

of Ophthalmology

8/07- 7/08 PGY-2 Ophthalmology resident : transferred to VCU

Kansas Univ. Dept of Ophthalmology

3/07- 6/07 Travel: Europe/Italy, Hawaii

1/06-1/07 Part-time Research Fellow w/ Dr. Sinha

University of Southern California (USC) Head and Neck Surgery

Los Angeles, CA

8/04-12/05 Dr. Gimbel and Dr. Song

Ophthalmology Research Fellow

Loma Linda Ophthalmology

Loma Linda, CA, USA

7/03-7/04 Dr. Karl Beutner, MD, PhD

Clinical Research Fellow

Solano Research

Vallejo/Davis, CA, USA

7/02-6/03 Dr. Tania Phillips

Research- Wound Healing & Clinical Fellow

Boston University Dermatology

Boston, Massachusetts, USA

7/01-6/2002 Internal Medicine- Preliminary Year

Berkshire Medical Center (Univ. of Massachusetts affiliate)

Pittsfield, Massachusetts, USA

Research Experience

10/09-04/11 Highlighting pain molecules via radiographic imaging: majority of time spent observing the clinical aspects of anesthesiology and ENT(perioperative care)

1/06-1/07 Part-time research fellow at USC Head & Neck Surgery, Dr. Sinha

Identifying tumor markers for squamous cell carcinoma of the head and neck

9/04-12/05 Ophthalmology Research Fellow: Served as the research fellow/coordinator for the program director and research chair; engaged in various retina studies that involve VEGF inhibitors (Genentech-sponsored study) and an upcoming pilot study for laser photocoagulation for DME; basically, developed clinical research department from stepping stone along with our regulatory coordinator.

Independent Projects

Acular Study for diabetic patients with cataracts: A Prospective 1 Year Study involving 2 cohorts (one cohort receives Predforte and Acular LS 2 weeks prior to cataract surgery and the second cohort receives no treatment prior to cataract surgery): Plan to enroll up to 75 patients and 15 patients (currently enrolled) : Objective is to determine whether anti-inflammatories reduce the incidence of macular edema prior to cataract surgery as opposed to standard therapy of anti-inflammatories S/P cataract surgery)

Adventist Health Study-2: Focused on identifying potential risk factor and/or benefits from the ongoing NIH-sponsored Adventist Health Study-2 (a relatively homogenous population with low incidence of smoking, alcohol intake, and a predominantly vegetarian diet) –investigating lifestyle/nutrition factors in the incidence of chronic diseases (i.e. cardiovascular, cancer, etc.): some preliminary evidence identifying the benefits of certain food groups;

Clinical Studies (NIH-sponsored and industry):

DRCR (Laser/Intravitreal/Peibulbar): NIH-sponsored trials comparing an intravitreal preservative-free steroid versus laser therapy for diabetic macular edema

Phase III trial of Genentech Lucentis for patients with all subtypes of wet AMD (2/3 chance of active treatment versus sham therapy)

Phase II trial Genaera/squalamine: an intravenous agent that inhibits neovascularization via multiple processes through growth signaling, cytoskeleton disruption, and endothelial apoptosis; ophthalmic assessments occur at Loma Linda ophthalmology and drug infusion takes place across at Loma Linda University Medical Center (LLUMC)

Regular Clinics & Surgery: Observed surgery and patient care in general clinic, including a number of photodynamic therapy administrations for research patients requiring Verteporfin PDT.

7/03-8/04 Clinical Research Fellow

Solano Clinical Research, Dr. Karl R. Beutner MD PHD

A clinical trials fellowship under the direction of

Karl R. Beutner, MD, Ph.D., Associate Clinical Professor UCSF, and VP and Chief Medical Officer at Dow Pharmaceutical Sciences.

Phase I to Phase III trials and in-depth understanding of guidelines to clinical practice. Dr. Beutner's expertise lies in cutaneous infections, notably cutaneous virology. His research site was one of the first sites to administer imiquimod for the treatment of condyloma acuminata. In the NEJM Nov. '02 issue regarding a controlled trial of HPV16 vaccine, Dr. Beutner was mentioned in the Proof of Principle Investigators. In addition, he is a co-author for the use of Valtrex in the transmission reduction among heterosexual, discordant couples for a NEJM article Jan ’04 article.

7/03-8/04 Clinical Research Fellow

Solano Clinical Research, Dr. Karl. R. Beutner MD PHD

Clinical Studies (not comprehensive list)

1)Phase I Cytomegalovirus vaccine (unique DNA-plasmid method)- a safety and immunogenicity trial in healthy adults (only 2 sites in the nation)

2)Herpes vaccine (a glycoprotein-subunit vaccine) for the prevention of herpes in double, sero-negative women

3)Efficacy of a polyvalent HPV vaccine with an immunogenicity bridge to monovalent HPV16 vaccine - A large randomized, double-blind, placebo-controlled, Phase III multicenter study to evaluate whether the polyvalent vaccine will reduce incidence of cervical cancer, vulvar intraepithelial neoplasia, and condyloma acuminata.

4)Compare the safety and immunogenicity of a new smallpox vaccine versus the standard Dryvax vaccine - A Phase III, multicenter, randomized study in naïve and previously vaccinated individuals.

5)Safety and Efficacy of "New Chemical Entity" in treatment of External Genital Warts - A multicenter, double-blind, three arm, placebo-controlled Phase III trial.

7/02-7/03 Clinical Research and Wound Healing Fellow

Boston University School of Medicine, Dr. Tania Phillips

Clinical Studies Description:

1) A "topical growth factor in subjects with venous ulcers - A randomized, double-blind, placebo-controlled, multi-center Phase III study to evaluate the efficacy and safety.

2) Daily cytokine subcutaneous injections in the treatment of psoriasis - A randomized, double-blind, placebo-controlled, Phase III pharmacogenomic study of a recombinant human "cytokine" in patients with active psoriasis.

3) A prospective, randomized, controlled clinical study to evaluate the effectiveness of a cellulose matrix wound dressing for autolytic debridement and healing of chronic venous ulcers.

4) A prospective, multicenter, randomized Phase III trial of a "bioengineered skin equivalent" in patients with venous leg ulcers.

7/02-7/03 Clinical Research Fellow

Boston University Department of Dermatology, Dr. Tania Phillips

I had an excellent opportunity to be involved in a research fellowship under Dr. Phillips at Boston University, Department of Dermatology and Vascular Surgery, whose expertise lies in wound healing. As main fellow of the wound healing clinic, I obtained significant experience in diagnosing and managing a diverse array of leg ulcers from the common diabetic/venous etiology to the unusual causes (RA, SLE, sarcoid, calciphylaxis, sarcoid, etc). Also, I wrote various manuscripts, which have been published.

6/98-8/98 Research Assistant

Loma Linda University School of Medicine, Drs. Cohen and Hardesty

One-third of women with breast implants develop breast capsular hardening due to the development of fibrosis. The purpose of the study was to evaluate the role of antibodies to TNF alpha and IL-1 in the prevention and/or reduction of breast capsular contracture. Basically, my role was to assist in the implantation of miniaturized breast implants into the dorsum of mice and assist with the injection of antibodies or placebo to evaluate the development of capsular fibrosis.

6/93-8/93 Lab Assistant

University of California, San Diego, Dr. Charles Zuker

Studied the role of mechano-transduction in the 2nd antenna segment of the chordotonal organ of Drosophila Melanogaster (fruit fly).

Publications & Power Point Presentations

Atypical Presentation of Colon Carcinoma: Initial Diagnosis of Metastatic Colorectal Carcinoma with Pathologic Humeral Fracture (Poster Presentation: May 2014)

Journal Club: Fidaxomicin vs Vancomycin for C-diff Colitis Powerpoint (PPT)

Presentation; 10/24/2012 St. Mary’s Medical Center Internal Medicine Dept

Atypical Case: Orbital Cellulitis Powerpoint (PPT) presentation: 06/02/2009 at Virginia Commonwealth Dept of Ophthalmology

Ocular Sarcoid; Powerpoint (PPT)presentation; 5/7/08 at Kansas Univ Dept of Ophthalmology

Conjunctival Lymphoma 2/26/2008 powerpoint (PPT) presentation (involving radiation oncology) at Kansas Univ Department of Ophthalmology

Narvaez J, Chakrabarty A, Chang Kenneth. “Treatment of epithelial ingrowth after LASIK enhancement with a combined technique of mechanical debridement, flap suturing, and fibrin glue application.” Cornea. 2006 Oct;25(9):1115-7.

Chakrabarty AK, Mraz S, Geisse JK, Anderson NJ. “Aphthous Ulcers Associated with Imiquimod and the treatment of actinic cheilitis” J Am Acad Dermatol 2005 Feb; 52 (Suppl 1): 35-7.

Chakrabarty A, Beutner KR. “Therapy of Other Viral Infections: Herpes to Hepatitis” for publication in “The Treatment Issue of Skin Infections” for Dermatologic Therapy guest editor Dr. Stephen Tyring; Dec 2004; 17(6): 465-490.

Chakrabarty A, Pang KR, Wu JJ, Narvaez J, Micheal R,, Huang DB, Beutner KR, Tyring SK. “Emerging Therapies for herpesvirus infections (types 1-8)” for Expert Opinon on Emerging Drugs Nov 2004; 9(2): 237-56.

Chakrabarty A, Tyring SK, Beutner KR, Michael R. “Recent clinical experience with famciclovir – a third generation nucleoside prodrug” Antiviral Chemistry & Chemotherapy Sep 2004; 15(5): 251-253.

Chakrabarty A, Phillips TJ. "Leg Ulcers of Unusual Causes", Lower Extremity Wounds 2003; 2(2): 1-9.

Chakrabarty A, Phillips TJ. "What is the diagnosis? Critical Leg Ischemia." Wounds. May 2003; 15(5): 167-172.

Chakrabarty A, Phillips TJ. "Necrobiosis Lipoidica (Diagnostic Dilemma)" Wounds. Feb 2003; 15(2): 59-62.

Chakrabarty A, Stefanato CM., Phillips TJ. "Pretibial Myxedema (Diagnostic Dilemma)" Wounds. Nov 2002; 14(9): 308-13.

Chakrabarty A, Phillips TJ. "Pyoderma gangrenosum (Diagnostic Dilemmas)" Wounds. Oct 2002; 14(8): 302-5.

Abstract/Poster Presentation/Protocol Design

Lin P, Chakrabarty A, Phillips TJ. "A Phase III, Prospective, Randomized Study of a foam composite dressing versus a hydrocellular foam pad. sponsored by Convatec, a Bristol-Myers Squibb company); no financial involvement." Poster Presentation at 16th Annual Symposium on Wound Care, April, 2003

Volunteer Experience

11/95-6/96 St. George's student volunteer

Medical student involved in distributing vaccinations, general medical history, and health education at a local orphanage in St. George's, Grenada.

4/90-8/90 Hospital volunteer

Volunteer during senior high school year. Part time voluntary during end of senior year high school at local community hospital. I assisted the elderly patients mainly by wheelchair transportation, feeding them, and talking with them.

Hobbies & Interests:

Snorkeling, kayaking, wave-running, soccer during medical school, avid reader of National Geographic and Scientific American magazine; fan of National Geographic Channel, international travel: India, Singapore, England, Italy, Egypt (most recent), etc.

Contact this candidate